EUVIMEDEUVIMED entdecken
Crossref

Extracorporeal Membrane Oxygenation Outcomes: COVID-19 Pneumonia vs Non–COVID-19 Pneumonia

Francisco J Gallegos-Koyner, Nelson I Barrera, Adisalem M Teferi, Katerina Jou, Roberto C Cerrud-Rodriguez, David H Chong

American Journal of Critical Care · 2025

DOI: 10.4037/ajcc2025524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Critical Care, 2025. Verfasst von Francisco J Gallegos-Koyner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Francisco J. Gallegos-Koyner is a resident physician at SBH Health System, Department of Internal Medicine, City University of New York School of Med…. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, COVID-19. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

COVID-19 can cause severe acute respiratory distress syndrome or myocardial dysfunction requiring extracorporeal membrane oxygenation (ECMO). Whether comorbidities or sociodemographic factors influence outcomes in these patients is unclear.

Methods

Adult patients from the National Inpatient Sample dataset with COVID-19 pneumonia or non–COVID-19 pneumonia who underwent ECMO between 2016 and 2021 were included. Cohorts were matched in a 1:5 ratio using propensity scores. The primary outcome of interest was inpatient mortality; secondary outcomes included length of stay, total hospitalization costs, need for dialysis, rate of vascular complications, and discharge disposition.

Results

Weighted patient groups (COVID-19 pneumonia, 5680 patients; non–COVID-19 pneumonia, 430 patients) were identified. Mean (SD) age was 46.0 (11.2) years in the COVID-19 group, 45.1 (12.5) years in the non–COVID-19 group. After matching, unweighted groups (COVID-19 pneumonia, 1136 patients; non–COVID-19 pneumonia, 86 patients) were compared. Patients with COVID-19 pneumonia had higher mortality risk (odds ratio [OR], 1.98; 95% CI, 1.11-3.53; P = .02), longer stays (38.0 vs 28.5 days, P < .001), higher costs ($1 278 270 vs $967 866, P = .002), and less likelihood of discharge home (OR, 0.42; 95% CI, 0.21-0.85; P = .02) than patients with non–COVID-19 pneumonia. Vascular complication rate (OR, 0.77; 95% CI, 0.27-2.26; P = .64) and need for dialysis (OR, 1.01; 95% CI, 0.49-2.08; P = .97) did not differ between groups.

Conclusions

Among patients undergoing ECMO, those with COVID-19 pneumonia had worse outcomes than those with non–COVID-19 pneumonia after adjustment for sociodemographic factors and comorbidities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationCOVID-19HumansMaleFemaleMiddle AgedHospital MortalityAdultLength of StayUnited StatesComorbidityPropensity ScoreTreatment OutcomeRetrospective StudiesSARS-CoV-2

Autor:innen und Institutionen

  • Francisco J. Gallegos-Koyner is a resident physician at SBH Health System, Department of Internal Medicine, City University of New York School of Medicine, Bronx, New York.
  • Nelson I. Barrera is a resident physician at SBH Health System, Department of Internal Medicine.
  • Adisalem M. Teferi is a resident physician at SBH Health System, Department of Internal Medicine.
  • Katerina Jou was a physician at SBH Health System, Department of Internal Medicine, and is now a general surgery resident, Northwell Health, New York.
  • Roberto C. Cerrud-Rodriguez is a cardiologist and vascular interventionist at Yale New Haven Hospital, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • David H. Chong is an associate professor, City University of New York School of Medicine, and a pulmonologist at SBH Health System, Department of Internal Medicine.

Zitieren

APA

Gallegos-Koyner, F. J., Barrera, N. I., Teferi, A. M., Jou, K., Cerrud-Rodriguez, R. C., & Chong, D. H. (2025). Extracorporeal Membrane Oxygenation Outcomes: COVID-19 Pneumonia vs Non–COVID-19 Pneumonia. American Journal of Critical Care. https://doi.org/10.4037/ajcc2025524

Vancouver

Gallegos-Koyner FJ, Barrera NI, Teferi AM, Jou K, Cerrud-Rodriguez RC, Chong DH. Extracorporeal Membrane Oxygenation Outcomes: COVID-19 Pneumonia vs Non–COVID-19 Pneumonia. American Journal of Critical Care. 2025. doi:10.4037/ajcc2025524

BibTeX
@article{GallegosKoyner2025,
  author = {Gallegos-Koyner, Francisco J and Barrera, Nelson I and Teferi, Adisalem M and Jou, Katerina and Cerrud-Rodriguez, Roberto C and Chong, David H},
  title = {Extracorporeal Membrane Oxygenation Outcomes: COVID-19 Pneumonia vs Non–COVID-19 Pneumonia},
  journal = {American Journal of Critical Care},
  year = {2025},
  doi = {10.4037/ajcc2025524}
}
Kostenlos starten →